Richard L. Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Elizabeth K. Spahn Editor Emeritus

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor

FCPA Blog Daily News

Entries in Novartis (17)


Bribery part of GSK business plan, China police say

Image courtesy of GlaxoSmithKlineA police investigation in China has found that drugmaker GlaxoSmithKline's alleged bribery of doctors ‘was coordinated by the British company and was not the work of individual employees,’ according to a report Tuesday by Reuters.

Click to read more ...


Drug sellers ‘take vacations’ amid China anti-graft campaign 

Pharmas have told their sales teams to halt all activity in China to avoid being caught in the nationwide “enforcement storm,” according to the Guangdong-based Yangcheng Evening News.

Click to read more ...


Pharma's China crack up

The headlines from Tuesday's ethiXbase Monitor, a daily email of global corruption and compliance news, tell the story.

Click to read more ...


Docs collect billions for drug promos

ProPublica ran an exposé this week about big bucks for doctors who promote products for drug companies.

Click to read more ...


The Novartis Speakers Bureau

There's an FCPA storm swirling around the drug makers. What will happen next?

Click to read more ...

Page 1 2